CROI webcast:
For individuals currently participating in a clinical trial involving retatrutide, or those who may access it through other means, recognising cardiac warning signs and knowing when to seek prompt medical attention is essential for patient safety
Clinical trials show tirzepatide users experience more rapid body-weight reduction and greater metabolic improvements, suggesting that a lower tirzepatide dose may deliver comparable or superior results to a higher semaglutide dose
Together, these findings highlight that although GLP-1 use may shift habits, it does not diminish the importance of restaurants in users routines
Watch for signs of low blood sugar: shakiness, rapid heartbeat, confusion, or excessive sweating, especially during the first 4 weeks
Having both options has made this so much easier to stay consistent with." Take the next step with the right guidance Take the next step with the right guidance Whether you prefer a structured weekly routine or a flexible daily option, the Nu Image Medical team is here to guide you